Boehringer Says Inhaler Antitrust Suit 'Fails On Its Face'
By Ryan Harroff · November 14, 2024, 5:53 PM EST
Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GMBH have urged a Connecticut federal judge to dismiss a proposed class action brought by health funds accusing it of monopolizing the inhaler...
To view the full article, register now.